Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Sampogna

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
International Journal of Dermatology|July 4, 2024
Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statementPavel Viktorovich Chernyshov, Lucia Tomas-Aragones, Torsten Zuberbier, et al.
Frontiers in Immunology|July 31, 2025
Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patientsRoberta Belli, Anna Dattolo, Francesca Sampogna, et al.
Journal of the American Academy of Dermatology|May 22, 2026
Linagliptin is a risk factor for bullous pemphigoid associated with BP180-NC16A/BP230 seronegativity and milder severity: evidence from a prospective case-control study supporting ECD-BP180 ELISA in reducing diagnostic delayAnna Pira, Adele Salemme, Feliciana Mariotti, et al.
International Journal of Dermatology|January 29, 2025
Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External ExpertsPavel V Chernyshov, Andrew Y Finlay, Lucia Tomas-Aragones, et al.
The Journal of Investigative Dermatology|December 19, 2014
The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countriesFlorence J Dalgard, Uwe Gieler, Lucia Tomas-Aragones, et al.
Acta Dermato-Venereologica|January 30, 2020
Psychosocial Aspects of Adult Acne: Data from 13 European CountriesIlknur K Altunay, Ezgi Özkur, Florence J Dalgard, et al.
Frontiers in Medicine|July 20, 2023
Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study-IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Acta Dermato-Venereologica|March 7, 2018
The Role of Therapy in Impairing Quality of Life in Dermatological Patients: A Multinational StudyFlora N Balieva, Andrew Y Finlay, Jörg Kupfer, et al.
Acta Dermato-Venereologica|September 19, 2018
Occurrence, Chronicity and Intensity of Itch in a Clinical Consecutive Sample of Patients with Skin Diseases: A Multi-centre Study in 13 European CountriesChristina Schut, Florence J Dalgard, Jon Anders Halvorsen, et al.
Acta Dermato-Venereologica|January 26, 2017
Attachment Styles of Dermatological Patients in Europe: A Multi-centre Study in 13 CountriesCsanád Szabó, Anita Altmayer, Lars Lien, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
International Journal of Dermatology|July 4, 2024
Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statementPavel Viktorovich Chernyshov, Lucia Tomas-Aragones, Torsten Zuberbier, et al.
Frontiers in Immunology|July 31, 2025
Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patientsRoberta Belli, Anna Dattolo, Francesca Sampogna, et al.
Journal of the American Academy of Dermatology|May 22, 2026
Linagliptin is a risk factor for bullous pemphigoid associated with BP180-NC16A/BP230 seronegativity and milder severity: evidence from a prospective case-control study supporting ECD-BP180 ELISA in reducing diagnostic delayAnna Pira, Adele Salemme, Feliciana Mariotti, et al.
International Journal of Dermatology|January 29, 2025
Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External ExpertsPavel V Chernyshov, Andrew Y Finlay, Lucia Tomas-Aragones, et al.
The Journal of Investigative Dermatology|December 19, 2014
The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countriesFlorence J Dalgard, Uwe Gieler, Lucia Tomas-Aragones, et al.
Acta Dermato-Venereologica|January 30, 2020
Psychosocial Aspects of Adult Acne: Data from 13 European CountriesIlknur K Altunay, Ezgi Özkur, Florence J Dalgard, et al.
Frontiers in Medicine|July 20, 2023
Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study-IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Acta Dermato-Venereologica|March 7, 2018
The Role of Therapy in Impairing Quality of Life in Dermatological Patients: A Multinational StudyFlora N Balieva, Andrew Y Finlay, Jörg Kupfer, et al.
Acta Dermato-Venereologica|September 19, 2018
Occurrence, Chronicity and Intensity of Itch in a Clinical Consecutive Sample of Patients with Skin Diseases: A Multi-centre Study in 13 European CountriesChristina Schut, Florence J Dalgard, Jon Anders Halvorsen, et al.
Acta Dermato-Venereologica|January 26, 2017
Attachment Styles of Dermatological Patients in Europe: A Multi-centre Study in 13 CountriesCsanád Szabó, Anita Altmayer, Lars Lien, et al.
Pageof 11